Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells. Sato-Nagaoka Y, Suzuki S, Suzuki S, Takahashi S, et al. PLoS One 2024;19:e0312406.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sato-Nagaoka Y, Suzuki S, Suzuki S, Takahashi S, et al. Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells. PLoS One 2024;19:e0312406.
PMID: 39739720